2 results match your criteria: "Pusan Nation University School of Medicine[Affiliation]"
A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Efficacy and Safety of Vibegron in Treating Korean Patients With Overactive Bladder.
Int Neurourol J
June 2023
Department of Urology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.
Purpose: Vibegron, a novel, potent β3 agonist, has been approved for clinical use in overactive bladder (OAB) treatment in Japan and the Unites States. We performed a bridging study to investigate the efficacy and safety of a daily 50-mg vibegron (code name JLP-2002) dose in Korean patients with OAB.
Methods: A multicenter, randomized, double-blind, placebo-controlled study was conducted from September 2020 to August 2021.
Pathophysiology and Management of Long-term Complications After Transvaginal Urethral Diverticulectomy.
Int Neurourol J
September 2021
Department of Urology, Pusan Nation University School of Medicine, Busan, Korea.
Article Synopsis
- Female urethral diverticulum (UD) is a rare condition characterized by an outpouching of the urethra, commonly presenting with symptoms like postmicturition dribble.
- The best way to diagnose UD is through magnetic resonance imaging (MRI), while the preferred treatment is transvaginal diverticulectomy, although it carries risks of complications like new stress urinary incontinence and recurrence.
- Management of complications can include conservative measures, surgical options like pubovaginal slings, or addressing any recurrent UD with additional surgical repair techniques, and malignancies in UD cases are extremely rare, typically managed with anterior pelvic exenteration.